Other formats:
BibTeX
LaTeX
RIS
@proceedings{1647497, author = {Selingerova, I. and Budinská, Eva and Zwinsová, Barbora and Mazalova, B. and Bencsikova, B. and Valik, D. and Dubska, L.Z.}, booktitle = {Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}, keywords = {blood group}, language = {eng}, title = {Anti-alpha gal antibodies in the context of blood group and stool and tumour-adjacent microbiome in colorectal cancer patients}, url = {https://www.annalsofoncology.org/article/S0923-7534(20)34474-4/pdf}, year = {2019} }
TY - CONF ID - 1647497 AU - Selingerova, I. - Budinská, Eva - Zwinsová, Barbora - Mazalova, B. - Bencsikova, B. - Valik, D. - Dubska, L.Z. PY - 2019 TI - Anti-alpha gal antibodies in the context of blood group and stool and tumour-adjacent microbiome in colorectal cancer patients KW - blood group UR - https://www.annalsofoncology.org/article/S0923-7534(20)34474-4/pdf L2 - https://www.annalsofoncology.org/article/S0923-7534(20)34474-4/pdf N2 - Gut microbiome plays a role in the development and clinical course of colorectal cancer (CRC). Natural antibodies against galactose-a-1,3-galactose (a-gal) are highly abundant in humans due to regular stimulation from gut bacteria. Similarly, Abs against AB0 blood group antigens are produced as cross-reacting with intestinal bacteria and a-gal epitope has similar structure to blood group B Ag. Blood group antigens may be associated with an expansion families of gut bacteria. ER -
SELINGEROVA, I., Eva BUDINSKÁ, Barbora ZWINSOVÁ, B. MAZALOVA, B. BENCSIKOVA, D. VALIK and L.Z. DUBSKA. Anti-alpha gal antibodies in the context of blood group and stool and tumour-adjacent microbiome in colorectal cancer patients. In \textit{Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}. 2019. ISSN~0923-7534.
|